NFKB1 and cardiovascular disorder: Overall, we conclude that the hepatocytic IKK:NF-κB axis plays a critical role in the initiation and progression of MAFLD by controlling lipogenesis and cholesterol synthesis, thus it might contribute to cardiovascular disease risk in MAFLD patients.